SYMBIOMIX THERAPEUTICS LLC has a total of 20 patent applications. Its first patent ever was published in 2013. It filed its patents most often in Republic of Korea, Canada and United States. Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are SOFTKEMO PHARMA CORP, PANOPTES PHARMA GES M B H and TREEWAY TW001 B V.
# | Country | Total Patents | |
---|---|---|---|
#1 | Republic of Korea | 5 | |
#2 | Canada | 4 | |
#3 | United States | 4 | |
#4 | WIPO (World Intellectual Property Organization) | 3 | |
#5 | Japan | 2 | |
#6 | EPO (European Patent Office) | 1 | |
#7 | United Kingdom | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Heterocyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Palling David | 12 |
#2 | Braun Carol J | 9 |
#3 | Pentikis Helen S | 9 |
#4 | Mcguffy Irena | 5 |
#5 | Jacks Robert | 5 |
#6 | Fonkwe Linus | 5 |
#7 | Holl Richard | 3 |
#8 | Amprey Joseph | 3 |
#9 | Vladyka Ronald S | 3 |
#10 | David Palling | 2 |
Publication | Filing date | Title |
---|---|---|
US2019008784A1 | Novel secnidazole soft gelatin capsule formulations and uses thereof | |
WO2016196653A1 | Novel nitroimidazole formulations and uses thereof | |
WO2016037131A1 | Secnidazole for use in the treatment of bacterial vaginosis | |
GB201310577D0 | Secnidazole |